Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Coagulation Factor VIII Prescribers(?)

Council Members in this Study Group: 24

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Jed Gorlin, MD
Transfusion Service Director
Hennepin County Medical Center

Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...

Forrest Rubenstein, MD
Cardiac, Thoracic and Vascular Surgeon
Rubenstein Cardiovascular and Thoracic Surgery

Forrest Rubenstein, MD, FACS, is a Cardiac, Thoracic and Vascular Surgeon in private practice. Dr. Rubenstein is board certified in General, Cardiovascular and Thoracic Surgery. He has experience in cardiac, thoracic and vascular surgery, aortic surgery, trauma, endovascular surgery, drug eluting stents,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Lenalidomide is on a surge | 06-02-2008
Author: GLG Expert Contributor

Lenalidomide is recently proving that its potential is not limited to myeloma, but can be used also in other B-cell malignancy settings such as lymphoma and CLL. CLL, in particular, needs light and yet efficacious treatments, particularly in the setting of pretreated (at times heavily) patients.

Hype and hope for another cancer vaccine | 04-02-2008
Author: GLG Expert Contributor

Biological efficacy has been shown for a number of cancer vaccines. Clinical efficacy has been shown in few of them. Clinical benefit just in one: idiotype vaccine for B-cell lymphoma. TroVax still has to clear the last hurdle, and likely also the second one.

Preventing Bariatric Surgery Deaths | 01-25-2008
Author: Forrest Rubenstein, MD, Cardiac, Thoracic and Vascular Surgeon, Rubenstein Cardiovascular and Thoracic Surgery

 Bariatric surgery is a major operative procedure that caries significant morbidity and mortality risks due to the comorbid diseases seen in this patient population.  This procedure is increasing in frequency as more patients are willing to have it and more surgeons are becoming proficient. The...

Another player in MM treatment? | 01-09-2008
Author: GLG Expert Contributor

Several novel compounds have recently changed the way myeloma is treated, but there is still plenty of room for improvement in myeloma treatment. This trial cold not just prove that tanespimycin works, but that also synergizes with a fashionable and efficacious agent like bortezomib&nb...

Orphan status does not mean efficacy | 11-30-2007
Analysis of: Vaxon Biotech Obtains Orphan Status for Lung Cancer Vaccine | www.therapeuticsdaily.com
Author: GLG Expert Contributor

Orphan status is a good thing to foster development of a compound/formulation Orphan status by no means allow to predict clinical efficacy or clinical benefit

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Lab, Academic Medical Center
  • Academic Institution*
  • Lab, Non-Academic/Community Hospital
  • Office Based Private Practice or Clinic
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Director
  • Physician - Department Chair
  • Owner
  • Medical Director
  • Research Scientist
  • Teaching Assistant

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-10-12T13:45:19.273